We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Q Doctor aims at changing the NHS care delivery with the help of video consulting to benefit patients and clinicians. The company is focusing on delivering a model that keeps modernised NHS care free of charge for the patients. The video solution plugs NHS clinicians to the existing NHS infrastructure and allows them to connect to the NHS patients digitally. With the proceeds, Q Doctor will fulfil its strategy for 2020. It will deploy the funds into labour, development, operations, marketing, and contingency funds.

Pitch Rated

51%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £1,386,200
Serious Pig (SP) aims to become the UK’s number one premium savoury snack brand. The company is backed by BrewDog co-founder James Watt and aims to become a contender in the UK savoury snack market valued at £3.2 billion. SP's range consists of products like 'Snack Salami', 'Snacking Cheese', and 'Snacking Pickles'. Its most recent innovation is 'Sourdough Snacking Croutons'. It has a loyal fanbase of nearly 9,000 'Club Seriously' members. The company's sales have trebled since 2018 to £1.35 million in December 2020. SP claims that despite COVID-19 shutting down hospitality in 2020, it quickly adapted and developed significant Direct-to-Consumer (DTC) revenue, in particular with Amazon, where sales grew by 235% between the first and second half of the year, touching £187,000 between June - December 2020. The company will use the investment for sales and marketing, logistics, New Product Development (NPD), and cut plastic packaging to reduce its carbon footprint.
days to go: Expired investment: £648,854
PLAYin CHOC is an innovative, premium and award-winning manufacturer of vegan organic eco-friendly toys and chocolates. Its products are allergen-free, plastic-free, 100% organic and inspire creative play. Since its launch, PLAYin CHOC has sold approximately 50,000+ units in 21 countries. Additionally, potential stockists for its products are estimated at 100,000 in the UK and 1 million globally. Now, PLAYin CHOC is planning to take its product to the market via high-end food supermarkets; independent food, confectionary and gift shops; travel retail market; direct to the consumer via subscription; and international distributors. Funds raised will be used to increase growth by securing larger and permanent premises and intensify targeted marketing at trade & consumer shows and online.
days to go: Expired investment: £278,450
Fighter Shots (FS) is a company that makes daily energy shots from a range of sources like ginger, turmeric and manuka honey to boost and strengthen human immunity. FS has sold over 50,000 bottles since its launch in November 2019. The functional drinks market has the potential to grow by $180 billion (11% CAGR) to $270 billion from 2020-24 on the back of COVID-19. FS aims to be a disruptor in this segment and asserts that its a dependable substitute to coffee and sugary drinks. It has secured listings with the Health Store, Tree of Life and DDC. The company is also developing sales in the United Arab Emirates (UAE). FS will use the investment to build its digital marketing and sales capabilities to bring its product to more customers.

Pitch Rated

73%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £160,000
Healthier Brands is a family business which provides innovative, fun and healthy snacks for kids and is loved by health-conscious adults as well. Its sales have doubled, and it has over 1000 retailer across the UK. Its current strategy is to provide natural products to the jelly market. Furthermore, its aim is to become a national family brand and to find its place in all the major multiple grocery stores by 2020. Healthier Brands has been featured in The Telegraph, Metro and countless local titles. The company will use the fund to drive growth, scale up sales and trade marketing supports with retailers.
days to go: Expired investment: £244,583
The Park Brewery (TPB) is a beer manufacturer. The company raised over £300,000 in its crowdfunding campaign in 2018. It has also managed to increase its sales from 100 pubs to 200. The company's beer is distributed around the UK via eight wholesalers. It also has onboarded notable clients like The Hilton, Honest Burgers, Fullers, and many more. TPB argues that it performed well despite Covid-19. It set up an e-commerce site and sold its products Direct-to-Customers (DTC), having completed around 2,000 home deliveries and gained over 1,700 new customers in 2020 throughout the lockdown. It will use the investment to develop its marketing strategy, increase direct sales, enhance its range, create more employment, and purchase additional tank space to meet demand.

Pitch Rated

83%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £229,999
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph